LYTIX BIOPHARMA ASA: årsregnskap 2005 vs 2004
Weaker earnings, fresh owner capital
Summary
What changed
Comparing Årsregnskap 2005 with 2004 for LYTIX BIOPHARMA ASA. Net result -2 144 NOK → -4.20m NOK. Equity 3 799 NOK → 4.34m NOK.
On the constructive side: equity strengthened; cash rose; owners injected capital. Pressures included: operating result weakened; net result weakened.
Net constructive year on the published lines.
At a glance
Scorecard
Revenue
n/m
19.9k NOK
—
Operating result
-2 152 NOK
-4.23m NOK
-196382.6%
Net result
-2 144 NOK
-4.20m NOK
-195994.2%
Equity
3 799 NOK
4.34m NOK
+114108.0%
Cash
3 975 NOK
5.17m NOK
+129936.5%
Total assets
5 142 NOK
7.07m NOK
+137391.1%
What improved
-
↑
Equity strengthened
Book equity 3 799 NOK → 4.34m NOK (equity ratio 73.9% → 61.4%). Calculated
-
↑
Cash rose
Bank deposits 3 975 NOK → 5.17m NOK (+129936.5% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 5 943 NOK → 10.69m NOK (+10.68m NOK). Reported fact
-
↑
Payroll decreased
Salary cost 6 282 NOK → 1 NOK. Calculated
What deteriorated
-
↓
Operating result weakened
Operating result -2 152 NOK → -4.23m NOK. Calculated
-
↓
Net result weakened
Net result -2 144 NOK → -4.20m NOK. Calculated